1.69  0.02 (1.2%)		12-08 15:59
Open: 1.7094 High: 1.73 Volume: 262,871		Pre. Close: 1.67 Low: 1.67 Market Cap: 62(M)

Short term
Mid term
Targets	6-month :	2.35	1-year :	2.63
Resists	First :	2.01	Second :	2.25
Pivot price	1.79
Supports	First :	1.62	Second :	1.35
MAs	MA(5) :	1.73	MA(20) :	1.85
	MA(100) :	3.25	MA(250) :	0
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	15.3	D(3) :	20
RSI	RSI(14): 40.4
52-week	High :	9	Low :	1.46

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ LITS ] has closed above bottom band by 19.5%. Bollinger Bands are 80.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 29 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	1.73 - 1.75	1.75 - 1.75
Low:	1.6 - 1.62	1.62 - 1.63
Close:	1.65 - 1.67	1.67 - 1.69

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Mon, 17 Nov 2025
Lite Strategy Reports Strong Q1 FY2026 Performance as $100M Litecoin Treasury Initiative Gains Traction - ZyCrypto

Mon, 17 Nov 2025
Lite Strategy becomes first US public company to hold Litecoin - Investing.com

Mon, 17 Nov 2025
Lite Strategy (NASDAQ: LITS) builds 929,548 LTC reserve and $25M buyback - Stock Titan

Wed, 29 Oct 2025
Lite Strategy Announces $25M Share Repurchase Program, - GlobeNewswire

Thu, 16 Oct 2025
Lite Strategy, Inc. Celebrates 14 Years of Litecoin as It Adopts LTC as Primary Reserve Asset - Quiver Quantitative

Sat, 04 Oct 2025
LITS Stock Price and Chart — NASDAQ:LITS - TradingView

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	37 (M)
Shares Float	56 (M)
Held by Insiders	17.5 (%)
Held by Institutions	27.5 (%)
Shares Short	141 (K)
Shares Short P.Month	323 (K)

EPS	-1.31
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	1.57
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-13.5 %
Return on Equity (ttm)	-16.9 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	-0.06
Sales Per Share	0
EBITDA (p.s.)	-0.42
Qtrly Earnings Growth	0 %
Operating Cash Flow	-14 (M)
Levered Free Cash Flow	-13 (M)

PE Ratio	-1.29
PEG Ratio	0
Price to Book value	1.07
Price to Sales	0
Price to Cash Flow	-4.46

Dividend	1.75
Forward Dividend	0
Dividend Yield	103.8%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.